glp-1 news today 2025-10-16 Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss GLP-1 and meal replacement resources

Should researchers compare blend names or component profiles

Recent studies show that GLP-1(936) can activate the inhibitory G protein (Gi/o), leading to the translocation of secretory granules (SG) beneath the cell membrane, thereby inhibiting glucagon secretion

Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials

Brand-name medications such as Ozempic and Wegovy may be prescribed when clinically appropriate and are FDA-approved for specific indications

That scale gives the paper visibility and makes it harder to dismiss, even if the final message remains cautious

These results show that adding supervised exercise during GLP-1 use improves weight loss maintenance after treatment termination